October 13 is Metastatic Breast Cancer Awareness Day. As of 2020, approximately 168,000 women in the U.S. were living with metastatic breast cancer (mBC), which is a projected 31% increase from 2010. This type of cancer, also called stage IV or advanced breast cancer, means it has metastasized, or spread, to other areas in the body such as the liver, lungs, brain, or bones.

My adrenaline now pumping, I knew what she was going to ask. I was already reaching into the back of a dark closet as the rep faintly suggested, “You wouldn’t happen to have…?” “Yes!” I replied excitedly. It was the Thursday before Easter and the cancer centre was closing for the four-day weekend, but I promised to scan the documents and email them to the rep before her return on Tuesday. My initial consultation with the lead oncologist was scheduled for the following Friday and there was no time to lose. “Let’s get this show on the road!” I rallied.

Firstly, I want to say that I am not sharing my story to encourage anyone to quit treatment. Please don’t! This is risky. I’m really rolling the dice here. I am choosing my quality of life over longevity. That’s not for everyone. I had been unable to tolerate any of the aromatase inhibitors (AI; a type of hormonal therapy used to lower estrogen levels to slow or stop cancer growth), so I felt I had little choice but to pursue other options.

I don’t need to tell you what was happening between 2019 and 2023. By May of 2022, I’d received four COVID-19 vaccinations and felt confident to attend a musical production with my niece. We were front row centre and seemed to be the only patrons with masks, soon discarded I must confess. When I found myself coughing a few days later I assumed it was COVID that I’d picked up in the theatre and left it to my presumed immunity to deal with.

In 2023, our most read blog posts reflect the interest that patients have in connecting with others, seeking support, and sharing experiences and personal stories. Diagnoses at a young age, parenting with breast cancer, living with mBC, and other personal stories made up most of our list. Lifestyle, the latest research, and different options for reconstruction fill out the topics that our readers were most interested in last year. Here CBCN presents our top 10 blog posts from 2023.

Our mother had breast cancer in her 50s, which increased her two daughters’ risk of also developing breast cancer. In 2005, my sister, Lorraine Smith, who was 41, enrolled in an early detection program and had her first mammogram. At the time, mammography reports were not disclosed to the patients, and they were not told anything about the density of their breasts, and what it means.

CBCN had the opportunity to attend the ABC7 conference in Lisbon, Portugal from November 9 to 11, 2023. Here are some highlights from the conference.

I am writing this from my hospital bed. One of many cancer-related hospital stays and visits. This hospital has become my second home. Fortunately, it’s a great hospital. That doesn’t mean I want to spend a lot of time here though. But that is inevitable when you have metastatic breast cancer, otherwise known as mBC. That is Stage IV cancer. Cancer that has travelled outside the breast and has metastasized into other areas of the body. 

I am a woman. I am active. I am a mom. I am also living with metastatic breast cancer, and I am living well. I have been active all my life. I played a variety of sports ever since I was little, like competitive fastball and hockey. So, how could a super active, fit, and healthy individual, with no breast cancer or any other type of cancer in her family, all of a sudden be told she has stage IV breast cancer?

Research on breast cancer, and more specifically, metastatic breast cancer (mBC), is critical in helping us better understand this disease. While widespread knowledge of mBC is still limited, there are studies that look specifically at the detection, prognosis and treatment of this type of breast cancer. Similarly, clinical trials on metastatic breast cancer are crucial in helping researchers improve the current standard of care. Below are some of the latest research and some currently recruiting clinical trials on metastatic breast cancer.

I am a 43-year-old mother of two amazing children, I have been in love with my wonderful Martin for 20 years now and I am a research professional in the health sector. Until August 2018, I was considered a breast cancer survivor. My cancer had been treated in the best way possible. My son was not yet one year old at the time (in 2012). I went through chemotherapy, radiotherapy, hormone therapy, a mastectomy and, finally, a breast reconstruction.

Every year on February 4^th, World Cancer Day, we get the opportunity to reflect on the work we’re doing to help reduce the impact of cancer. World Cancer Day, led by the Union for International Cancer Control (UICC), has an action packed slogan: I Am and I Will. They’ve developed a set of key issues that affects us all. Here’s how CBCN is working to reduce the affects of cancer for Canadians based on these key issues:

When people think of therapy the most common therapy session that comes to mind probably includes a person sitting across from or lying down beside a therapist and talking about their feelings. But what if you can never quite find the right words to say to express yourself or talking through what you are feeling doesn’t seem to be helping? The truth is therapy comes in all shapes and sizes. People are looking for and creating new ways to help cope with the stresses in their lives.

On July 19, 2011, at the age of 33, I was diagnosed with breast cancer. With a 10-month-old son, I was still glowing with the joy of motherhood—but when a lump that I had been attributing to breastfeeding challenges refused to go away, I decided to see my doctor.